Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Revive Therapeutics Ltd. C.RVV

Alternate Symbol(s):  RVVTF

Healthcare
Revive Therapeutics Ltd. is a Canada-based life sciences company. The Company is focused on the research and development of therapeutics for rare disorders and infectious diseases. The Company is exploring the use of Bucillamine for the treatment of infectious diseases, with an initial focus on severe influenza and COVID-19. Through its subsidiary, Psilocin Pharma Corp., the Company is... see more

Recent & Breaking News (CSE:RVV)

Revive Therapeutics Provides Update on FDA Phase 3 Clinical Trial for Bucillamine in COVID-19 with Plans on Emergency Use Access

GlobeNewswire December 23, 2020

PharmaTher Signs LOI to Sell Psilocybin Program to Revive Therapeutics

GlobeNewswire December 21, 2020

Revive Therapeutics Announces LOI to Acquire PharmaTher's Psilocybin Program

GlobeNewswire December 21, 2020

Epidemiologist Dr. Joel Moody Joins Revive Therapeutics as Medical and Clinical Advisor

GlobeNewswire December 2, 2020

Psilocybin Medical Play Advances Business, Ready for Next Stage

Stockhouse Editorial November 25, 2020

PharmaTher Provides Update on its Psychedelic Pharmaceuticals Programs

GlobeNewswire November 24, 2020

PharmaTher & Revive Therapeutics Team-Up to Investigate Psychedelic Cancer Treatment Therapies

Stockhouse Editorial November 18, 2020

This Could be Game-Changing News for Psilocybin's Treatment of Mental Health

Livemoney November 18, 2020

Revive Therapeutics Announces Research Collaboration with PharmaTher for Development of Psilocybin in Cancer and Discovery of Novel Uses of Psychedelics

GlobeNewswire November 18, 2020

PharmaTher Enters Into Research Collaboration with Revive Therapeutics for Psilocybin and panaceAI(TM) Psychedelic Discovery AI Platform

GlobeNewswire November 18, 2020

Aside from Depression, Psilocybin May Be a Natural Appetite Suppressant

Livemoney November 12, 2020

Psilocybin - One of the Biggest Winners of the 2020 U.S. Election

Livemoney November 11, 2020

Revive Therapeutics Provides Update on Oral Thin Film Product with Psilocybin

GlobeNewswire November 11, 2020

Revive Therapeutics Provides Update on FDA Phase 3 Clinical Trial for Bucillamine in COVID-19

GlobeNewswire October 26, 2020

InvestmentPitch Media Video Discusses Revive Therapeutics' supply agreement with Havn Life Sciences for Psychedelic Compounds - Video Available on Investmentpitch.com

Newsfile October 21, 2020

The Potential $100 Billion Psychedelics Boom Investors Should Watch

Livemoney October 20, 2020

Revive Therapeutics Signs Supply Agreement With Havn Life Sciences for Psychedelic Compounds

GlobeNewswire October 20, 2020

The StockTalk Cannabis Report: Oct. 2, 2020

Dave Jackson October 2, 2020

Surging Psychedelic Stock Backed by University Study

Stockhouse Editorial October 1, 2020

The World May be Nearing Treatments for the Growing Pandemic

Livemoney September 29, 2020